Skip to main content
. 2019 Nov;7(22):670. doi: 10.21037/atm.2019.10.34

Figure 2.

Figure 2

Score of the signatures of different responses of NCT identified before and after NCT (performed by PLS-DA) (A) Signatures of SD and PR patients both have great changes after chemotherapy, separately; (B) signatures of SD patients and PR patients classified obviously before NCT start; (C) signatures of SD patients and PR patients classified after NCT. NCT, neoadjuvant chemotherapy; PLS-DA, partial least squares discriminant analysis; SD, stable disease; PR, partial response.